Correlation
The correlation between TECH and PFE is 0.44, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
TECH vs. PFE
Compare and contrast key facts about Bio-Techne Corporation (TECH) and Pfizer Inc. (PFE).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: TECH or PFE.
Performance
TECH vs. PFE - Performance Comparison
Loading data...
Key characteristics
TECH:
-0.91
PFE:
-0.63
TECH:
-1.31
PFE:
-0.54
TECH:
0.84
PFE:
0.94
TECH:
-0.59
PFE:
-0.20
TECH:
-1.89
PFE:
-0.81
TECH:
20.02%
PFE:
14.43%
TECH:
40.46%
PFE:
24.08%
TECH:
-74.39%
PFE:
-58.96%
TECH:
-63.21%
PFE:
-54.77%
Fundamentals
TECH:
$7.62B
PFE:
$133.38B
TECH:
$0.83
PFE:
$1.38
TECH:
58.57
PFE:
17.00
TECH:
1.33
PFE:
0.60
TECH:
6.30
PFE:
2.14
TECH:
3.78
PFE:
1.48
TECH:
$1.21B
PFE:
$62.46B
TECH:
$796.33M
PFE:
$42.09B
TECH:
$284.25M
PFE:
$17.24B
Returns By Period
In the year-to-date period, TECH achieves a -32.32% return, which is significantly lower than PFE's -8.82% return. Over the past 10 years, TECH has outperformed PFE with an annualized return of 7.79%, while PFE has yielded a comparatively lower 0.87% annualized return.
TECH
-32.32%
-3.57%
-35.88%
-36.71%
-18.33%
-5.15%
7.79%
PFE
-8.82%
-1.67%
-5.36%
-15.01%
-19.97%
-2.98%
0.87%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
TECH vs. PFE — Risk-Adjusted Performance Rank
TECH
PFE
TECH vs. PFE - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Bio-Techne Corporation (TECH) and Pfizer Inc. (PFE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
TECH vs. PFE - Dividend Comparison
TECH's dividend yield for the trailing twelve months is around 0.66%, less than PFE's 7.28% yield.
TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
TECH Bio-Techne Corporation | 0.66% | 0.44% | 0.41% | 0.77% | 0.25% | 0.40% | 0.58% | 0.88% | 0.99% | 1.24% | 1.42% | 1.35% |
PFE Pfizer Inc. | 7.28% | 6.33% | 5.70% | 3.12% | 2.64% | 3.92% | 3.68% | 3.12% | 3.53% | 3.69% | 3.47% | 3.34% |
Drawdowns
TECH vs. PFE - Drawdown Comparison
The maximum TECH drawdown since its inception was -74.39%, which is greater than PFE's maximum drawdown of -58.96%. Use the drawdown chart below to compare losses from any high point for TECH and PFE.
Loading data...
Volatility
TECH vs. PFE - Volatility Comparison
Bio-Techne Corporation (TECH) has a higher volatility of 15.50% compared to Pfizer Inc. (PFE) at 8.90%. This indicates that TECH's price experiences larger fluctuations and is considered to be riskier than PFE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
TECH vs. PFE - Financials Comparison
This section allows you to compare key financial metrics between Bio-Techne Corporation and Pfizer Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
TECH vs. PFE - Profitability Comparison
TECH - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2025, Bio-Techne Corporation reported a gross profit of 214.56M and revenue of 316.18M. Therefore, the gross margin over that period was 67.9%.
PFE - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2025, Pfizer Inc. reported a gross profit of 10.87B and revenue of 13.72B. Therefore, the gross margin over that period was 79.3%.
TECH - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2025, Bio-Techne Corporation reported an operating income of 38.71M and revenue of 316.18M, resulting in an operating margin of 12.2%.
PFE - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2025, Pfizer Inc. reported an operating income of 4.43B and revenue of 13.72B, resulting in an operating margin of 32.3%.
TECH - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2025, Bio-Techne Corporation reported a net income of 22.59M and revenue of 316.18M, resulting in a net margin of 7.1%.
PFE - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2025, Pfizer Inc. reported a net income of 2.97B and revenue of 13.72B, resulting in a net margin of 21.6%.